Last reviewed · How we verify
C52R1L, C52R1M — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
C52R1L, C52R1M (C52R1L, C52R1M) — AJU Pharm Co., Ltd.. C52R1L and C52R1M are investigational drugs with unknown mechanisms of action.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| C52R1L, C52R1M TARGET | C52R1L, C52R1M | AJU Pharm Co., Ltd. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- C52R1L, C52R1M CI watch — RSS
- C52R1L, C52R1M CI watch — Atom
- C52R1L, C52R1M CI watch — JSON
- C52R1L, C52R1M alone — RSS
Cite this brief
Drug Landscape (2026). C52R1L, C52R1M — Competitive Intelligence Brief. https://druglandscape.com/ci/c52r1l-c52r1m. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab